Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEQUENCE: Nab-paclitaxel and Gemcitabine followed by mFOLFOX in Pancreatic Cancer
NCT02504333Phase 2Completed
- Sponsor
- Spanish Cooperative Group for Digestive Tumour Therapy
- Start
- Jul 2015
- Primary completion
- Apr 2021
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, fluorouracil, folinic acid in pancreatic adenocarcinoma (PDAC), sponsored by Spanish Cooperative Group for Digestive Tumour Therapy. Started Jul 2015; status: completed.
02
Drugs
oxaliplatinfluorouracilfolinic acid
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT02504333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02504333.